LYZZ Capital

LYZZ Capital is a global healthcare-dedicated venture capital and private equity firm. It identifies and supports companies across the healthcare sector, including medical devices, services, and digitalization. The firm leverages a team with deep expertise in pharmaceuticals, biotech, and finance, applying a disciplined investment strategy focused on value, business judgment, and forward-looking analysis.

Co-founded by Kevin Li, a Managing Partner, LYZZ Capital was established in 2014. The firm emerged from recognizing compelling investment opportunities within the global healthcare landscape, particularly those addressing unmet medical needs. Dr. Li brings over two decades of experience in biomedical sciences and healthcare investment, fundamentally shaping its approach.

LYZZ Capital invests in early-to-growth-stage companies in life sciences and healthcare worldwide. Its vision centers on talents, assets, and technologies that tackle critical healthcare challenges and foster innovation. By concentrating on businesses fulfilling substantial medical needs, the firm endeavors to advance global health solutions and achieve enduring value.